.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
Healthtrust
QuintilesIMS
US Department of Justice
Mallinckrodt
Dow
Citi
Johnson and Johnson
Cipla

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075731

« Back to Dashboard
NDA 075731 describes CLORAZEPATE DIPOTASSIUM, which is a drug marketed by Quantum Pharmics, Mylan, Sun Pharm Inds Ltd, Aurolife Pharma Llc, Lederle, Purepac Pharm, Gd Searle Llc, Warner Chilcott, Am Therap, Taro Pharm, Dava Pharms Inc, Usl Pharma, Watson Labs, and Able, and is included in fifty-eight NDAs. It is available from eight suppliers. Additional details are available on the CLORAZEPATE DIPOTASSIUM profile page.

The generic ingredient in CLORAZEPATE DIPOTASSIUM is clorazepate dipotassium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.

Summary for 075731

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 075731

Ingredient-typeBenzodiazepines

Medical Subject Heading (MeSH) Categories for 075731

Suppliers and Packaging for NDA: 075731

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL 075731 ANDA Rebel Distributors Corp 21695-433 21695-433-60 60 TABLET in 1 BOTTLE (21695-433-60)
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL 075731 ANDA Rebel Distributors Corp 21695-434 21695-434-60 60 TABLET in 1 BOTTLE (21695-434-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Apr 27, 2000TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Apr 27, 2000TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3.75MG
Approval Date:Apr 27, 2000TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
McKesson
Argus Health
Dow
Federal Trade Commission
Medtronic
Teva
Healthtrust
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot